Digital Pathology Market by Type (Scanners, Software, and Storage & Communication Systems), Application (Teleconsultation, Disease Diagnosis, Drug Discovery, and Training & Education), and End User (Educational, Clinical, and Pharma & Biotech Companies): Global Opportunity Analysis and Industry Forecast, 2021––2030
The global digital pathology market was valued at $735.75 million in 2020, and is expected to reach $1791.30 million by 2030, registering a CAGR of 9.3%, registering a CAGR of 9.3% from 2021 to 2030. Digital pathology is a computer-enabled, image-based information platform that helps for the management of information generated from digital slides.. Digital pathology solution offers scrutiny & analysis of images on a computer, high-resolution sample scanning, and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences.
The affordable cost of digital pathology products, convenience of virtual slide transportation, and high efficiency of digital pathology systems are the major factors that boost the growth of the global digital pathology market. Furthermore, the market is being driven by an increase in usage of digital pathology solutions as compared to conventional pathology diagnosis. In addition, developing technologies in digital pathology systems, such as digital microscopy, are important tools in surgical pathology. Increase in interest among pathologists for diagnostic, educational and research purposes increases the usage of digital pathology systems in drug discovery. These aforementioned factors have fueled the market growth. On the contrary, high cost associated with digital pathology systems restrains the market growth. However, rise in initiatives toward commercialization of cost-efficient digital pathology systems is anticipated to offer profitable growth opportunities for service providers in the future.
According to the data published by Journal of Clinical Medicine, digital pathology is becoming a mainstream option for routine diagnostics. Faster whole slide image scanning is the main way for this development and implementation of new technologies in digital pathology systems. These advantages associated with digital pathology system boost the market growth. In addition, as per the Journal of Pathology, the digital pathology provides greater accuracy and standardization of pathology based trial criteria. The digital pathology platforms improve the training and performance of clinical trial pathologists. Furthermore, increase in number of teleconsultations and rise in adoption of digital pathology systems to enhance lab efficiency drives the growth of the digital pathology market.
According to the International Agency for Research on Cancer (IARC), the updated Globocan data of 2020, around 19.3 million cases of cancer were estimated. According to The World Health Organization (WHO), cancer is a leading cause of death worldwide and approximately 70% of deaths from cancer occur in low & middle income countries. By 2040, the number of new cases of cancer per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to increase to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the growth of digital pathology market.
In addition, technological advancements for development of new products, growth in patient emphasis for early detection of diseases, and rise in global prevalence of targeted diseases along with surge in geriatric population, are factors that are anticipated to drive the growth of the digital pathology market.
On the contrary, high cost of implementation of digital pathology systems &maintenance, compliance with regulatory requirements in developing countries, lack of reimbursement in some countries, and adverse side effects of radiation emitted from digital pathology systems can lead to cancer as well hinder the growth of the market.
Emerging markets and extensive R&D to build effective digital pathology systems, innovation of various systems, and unmet demand for digital pathology systems in the underdeveloped & developing countries are projected to provide substantial growth opportunities for key players in the digital pathology market.
The digital pathology market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is categorized into scanners, software, and storage & communication systems. On the basis of application, it is classified into teleconsultation, disease diagnosis, drug discovery, and training & education. On the basis of end user, the market is fragmented into educational, clinical, and pharma & biotech companies. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and, rest of Asia-Pacific) ,and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Some of the major companies that operate in the global digital pathology market are 3DHISTECH LTD, Danaher Corporation, Glencoe Software Inc., HAMAMTSU Photonics K.K, Indica Labs Inc., Koninklijke Philips N.V, Nikon Corporation, Perkinelmer Inc., Roche, and VisoPharma A/S.
KEY BENEFITS FOR STAKEHOLDERS
This report provides an extensive analysis of the current and emerging market trends and dynamics in the global digital pathology market to identify the prevailing opportunities.
This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Product Type
Scanners
Software
Storage & Communication Systems
By Application
Teleconsultation
Disease Diagnosis
Drug Discovery
Training & Education
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
3DHISTECH Ltd
Danaher Corporation
Glencoe Software Inc.
HAMAMTSU Photonics K.K
Indica Labs Inc.
Koninklijke Philips N.V
Nikon Corporation
Perkinelmer Inc.
Roche
VisoPharma A/S
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key benefits for stakeholders
- 1.3.Key market segments
- 1.4.Research methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools & models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Market dynamics
- 3.4.1.Drivers
- 3.4.1.1.Use of digital pathology in disease diagnosis
- 3.4.1.2.Increase in trend of digitalization in the medical sector
- 3.4.1.3.Ease of consultation
- 3.4.1.4.Diagnosis in remote regions
- 3.4.2.Restraints
- 3.4.2.1.Lack of reimbursement policies
- 3.4.2.2.High cost of digital pathology solutions
- 3.4.3.Opportunity
- 3.4.3.1.Increase in potential of digital pathology
- 3.4.4.Impact analyses
- CHAPTER 4:DIGITAL PATHOLOGY MARKET, BY PRODUCT
- 4.1.Overview
- 4.1.1.Market size and forecast
- 4.2.Scanners
- 4.2.1.Key market trends, growth factors and opportunities
- 4.2.2.Market size and forecast
- 4.2.3.Market analysis, by country
- 4.3.Software
- 4.3.1.Key market trends, growth factors and opportunities
- 4.3.2.Market size and forecast
- 4.3.3.Market analysis, by country
- 4.4.Storage and Communication Systems
- 4.4.1.Key market trends, growth factors and opportunities
- 4.4.2.Market size and forecast
- 4.4.3.Market analysis, by country
- CHAPTER 5:DIGITAL PATHOLOGY MARKET, BY APPLICATION
- 5.1.Overview
- 5.1.1.Market size and forecast
- 5.2.Teleconsultation
- 5.2.1.Market size and forecast
- 5.2.2.Market analysis, by country
- 5.3.Disease diagnosis
- 5.3.1.Market size and forecast
- 5.3.2.Market analysis, by country
- 5.4.Drug Discovery
- 5.4.1.Market size and forecast
- 5.4.2.Market analysis, by country
- 5.5.Training & Education
- 5.5.1.Market size and forecast
- 5.5.2.Market analysis, by country
- CHAPTER 6:DIGITAL PATHOLOGY MARKET, BY END USER
- 6.1.Overview
- 6.1.1.Market size and forecast
- 6.2.Educational
- 6.2.1.Market size and forecast
- 6.2.2.Market analysis, by country
- 6.3.Clinical
- 6.3.1.Market size and forecast
- 6.3.2.Market analysis, by country
- 6.4.Pharma & biotech companies
- 6.4.1.Market size and forecast
- 6.4.2.Market analysis, by country
- CHAPTER 7:DIGITAL PATHOLOGY MARKET, BY REGION
- 7.1.Overview
- 7.1.1.Market size and forecast
- 7.2.North America
- 7.2.1.Key market trends and opportunities
- 7.2.2.North America market size & forecast, by country
- 7.2.3.North America market size & forecast, by product
- 7.2.4.North America market size & forecast, by application
- 7.2.5.North America market size & forecast, by end user
- 7.2.6.U.S.
- 7.2.6.1.U.S. market size & forecast, by product
- 7.2.6.2.U.S. market size & forecast, by application
- 7.2.6.3.U.S. market size & forecast, by end user
- 7.2.7.Canada
- 7.2.7.1.Canada market size & forecast, by product
- 7.2.7.2.Canada market size & forecast, by application
- 7.2.7.3.Canada market size & forecast, by end user
- 7.2.8.Mexico
- 7.2.8.1.Mexico market size & forecast, by product
- 7.2.8.2.Mexico market size & forecast, by application
- 7.2.8.3.Mexico market size & forecast, by end user
- 7.3.Europe
- 7.3.1.Key trends and opportunities
- 7.3.2.Europe market size & forecast, by country
- 7.3.3.Europe market size & forecast, by product
- 7.3.4.Europe market size & forecast, by application
- 7.3.5.Europe market size & forecast, by end user
- 7.3.6.Germany
- 7.3.6.1.Germany market size & forecast, by product
- 7.3.6.2.Germany market size & forecast, by application
- 7.3.6.3.Germany market size & forecast, by end user
- 7.3.7.France
- 7.3.7.1.France market size & forecast, by product
- 7.3.7.2.France market size & forecast, by application
- 7.3.7.3.France market size & forecast, by end user
- 7.3.8.UK
- 7.3.8.1.UK market size & forecast, by product
- 7.3.8.2.UK market size & forecast, by application
- 7.3.8.3.UK market size & forecast, by end user
- 7.3.9.Italy
- 7.3.9.1.Italy market size & forecast, by product
- 7.3.9.2.Italy market size & forecast, by application
- 7.3.9.3.Italy market size & forecast, by end user
- 7.3.10.Spain
- 7.3.10.1.Spain market size & forecast, by product
- 7.3.10.2.Spain market size & forecast, by application
- 7.3.10.3.Spain market size & forecast, by end user
- 7.3.11.Rest of Europe
- 7.3.11.1.Rest of Europe market size & forecast, by product
- 7.3.11.2.Rest of Europe market size & forecast, by application
- 7.3.11.3.Rest of Europe market size & forecast, by end user
- 7.4.Asia-Pacific
- 7.4.1.Key trends and opportunities
- 7.4.2.Asia-Pacific market size & forecast, by country
- 7.4.3.Asia-Pacific market size & forecast, by product
- 7.4.4.Asia-Pacific market size & forecast, by application
- 7.4.5.Asia-Pacific market size & forecast, by end user
- 7.4.6.Japan
- 7.4.6.1.Japan market size & forecast, by product
- 7.4.6.2.Japan market size & forecast, by application
- 7.4.6.3.Japan market size & forecast, by end user
- 7.4.7.China
- 7.4.7.1.China market size & forecast, by product
- 7.4.7.2.China market size & forecast, by application
- 7.4.7.3.China market size & forecast, by end user
- 7.4.8.Australia
- 7.4.8.1.Australia market size & forecast, by product
- 7.4.8.2.Australia market size & forecast, by application
- 7.4.8.3.Australia market size & forecast, by end user
- 7.4.9.India
- 7.4.9.1.India market size & forecast, by product
- 7.4.9.2.India market size & forecast, by application
- 7.4.9.3.India market size & forecast, by end user
- 7.4.10.South Korea
- 7.4.10.1.South Korea market size & forecast, by product
- 7.4.10.2.South Korea market size & forecast, by application
- 7.4.10.3.South Korea market size & forecast, by end user
- 7.4.11.Rest of Asia-Pacific
- 7.4.11.1.Rest of Asia-Pacific market size & forecast, by product
- 7.4.11.2.Rest of Asia-Pacific market size & forecast, by application
- 7.4.11.3.Rest of Asia-Pacific market size & forecast, by end user
- 7.5.LAMEA
- 7.5.1.Key trends and opportunities
- 7.5.2.LAMEA market size & forecast, by country
- 7.5.3.LAMEA market size & forecast, by product
- 7.5.4.LAMEA market size & forecast, by application
- 7.5.5.LAMEA market size & forecast, by end user
- 7.5.6.Brazil
- 7.5.6.1.Brazil market size & forecast, by product
- 7.5.6.2.Brazil market size & forecast, by application
- 7.5.6.3.Brazil market size & forecast, by end user
- 7.5.7.Saudi Arabia
- 7.5.7.1.Saudi Arabia market size & forecast, by product
- 7.5.7.2.Saudi Arabia market size & forecast, by application
- 7.5.7.3.Saudi Arabia market size & forecast, by end user
- 7.5.8.South Africa
- 7.5.8.1.South Africa market size & forecast, by product
- 7.5.8.2.South Africa market size & forecast, by application
- 7.5.8.3.South Africa market size & forecast, by end user
- 7.5.9.Rest of LAMEA
- 7.5.9.1.Rest of LAMEA market size & forecast, by product
- 7.5.9.2.Rest of LAMEA market size & forecast, by application
- 7.5.9.3.Rest of LAMEA market size & forecast, by end user
- CHAPTER 8:COMPETITIVE LANDSCAPE
- 8.1.Top player positioning
- 8.2.Competitive dashboard
- 8.3.Competitive heatmap
- CHAPTER 9:COMPANY PROFILES
- 9.1.3DHISTECH LTD.
- 9.1.1.Company overview
- 9.1.2.Company snapshot
- 9.1.3.Operating business segments
- 9.1.4.Product portfolio
- 9.1.5.Key strategic moves and developments
- 9.2.DANAHER CORPORATION (LEICA MICROSYSTEM)
- 9.2.1.Company overview
- 9.2.2.Company snapshot
- 9.2.3.Operating business segments
- 9.2.4.Product portfolio
- 9.2.5.Business performance
- 9.2.6.Key strategic moves and developments
- 9.3.GLENCOE SOFTWARE, INC.
- 9.3.1.Company overview
- 9.3.2.Company snapshot
- 9.3.3.Operating business segments
- 9.3.4.Product portfolio
- 9.4.HAMAMATSU PHOTONICS K.K.
- 9.4.1.Company overview
- 9.4.2.Company snapshot
- 9.4.3.Operating business segments
- 9.4.4.Product portfolio
- 9.4.5.Business performance
- 9.4.6.Key strategic moves and developments
- 9.5.INDICA LABS INC.
- 9.5.1.Company overview
- 9.5.2.Company snapshot
- 9.5.3.Operating business segments
- 9.5.4.Product portfolio
- 9.5.5.Key strategic moves and developments
- 9.6.KONINKLIJKE PHILIPS N.V.
- 9.6.1.Company overview
- 9.6.2.Company snapshot
- 9.6.3.Operating business segments
- 9.6.4.Product portfolio
- 9.6.5.Business performance
- 9.6.6.Key strategic moves and developments
- 9.7.NIKON CORPORATION
- 9.7.1.Company overview
- 9.7.2.Company snapshot
- 9.7.3.Operating business segments
- 9.7.4.Product portfolio
- 9.7.5.Business performance
- 9.7.6.Key strategic moves and developments
- 9.8.PERKINELMER INC.
- 9.8.1.Company overview
- 9.8.2.Company snapshot
- 9.8.3.Operating business segments
- 9.8.4.Product portfolio
- 9.8.5.Business performance
- 9.9.F- HOFFMANN LA-ROCHE (ROCHE)
- 9.9.1.Company overview
- 9.9.2.Company snapshot
- 9.9.3.Operating business segments
- 9.9.4.Product portfolio
- 9.9.5.Business performance
- 9.9.6.Key strategic moves and developments
- 9.10.VISIOPHARM A/S
- 9.10.1.Company overview
- 9.10.2.Company snapshot
- 9.10.3.Operating business segments
- 9.10.4.Product portfolio
- 9.10.5.Key strategic moves and developments
- List of Tables
- TABLE 01.GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 02.DIGITAL PATHOLOGY MARKET FOR SCANNERS, BY REGION, 2018–2026 ($MILLION)
- TABLE 03.DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY REGION, 2018–2026 ($MILLION)
- TABLE 04.DIGITAL PATHOLOGY MARKET FOR STORAGE AND COMMUNICATION SYSTEMS, BY REGION, 2018–2026 ($MILLION)
- TABLE 05.GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 06.DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY REGION, 2018–2026 ($MILLION)
- TABLE 07.DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2018–2026 ($MILLION)
- TABLE 08.DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY REGION, 2018–2026 ($MILLION)
- TABLE 09.DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY REGION, 2018–2026 ($MILLION)
- TABLE 10.GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2019-2026 ($MILLION)
- TABLE 11.GLOBAL DIGITAL PATHOLOGY MARKET FOR EDUCATIONAL SECTOR, BY REGION, 2019-2026 ($MILLION)
- TABLE 12.DIGITAL PATHOLOGY MARKET FOR CLINICAL SECTOR, BY REGION, 2019-2026 ($MILLION)
- TABLE 13.DIGITAL PATHOLOGY MARKET FOR PHARMA & BIOTECH COMPANIES, BY REGION, 2019-2026 ($MILLION)
- TABLE 14.DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2026 ($MILLION)
- TABLE 15.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2026 ($MILLION)
- TABLE 16.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 17.NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 18.NORTH AMERICA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 19.U.S. DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 20.U.S. DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 21.U.S. DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 22.CANADA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 23.CANADA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 24.CANADA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 25.MEXICO DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 26.MEXICO DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 27.MEXICO DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 28.EUROPE DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
- TABLE 29.EUROPE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 30.EUROPE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 31.EUROPE DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 32.GERMANY DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 33.GERMANY DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 34.GERMANY DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 35.FRANCE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 36.FRANCE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 37.FRANCE DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 38.UK DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 39.UK DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 40.UK DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 41.ITALY DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 42.ITALY DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 43.ITALY DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 44.SPAIN DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 45.SPAIN DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 46.SPAIN DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 47.REST OF EUROPE DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 48.REST OF EUROPE DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 49.REST OF EUROPE DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 50.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
- TABLE 51.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 52.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 53.ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 54.JAPAN DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 55.JAPAN DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 56.JAPAN DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 57.CHINA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 58.CHINA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 59.CHINA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 60.AUSTRALIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 61.AUSTRALIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 62.AUSTRALIA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 63.INDIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 64.INDIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 65.INDIA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 66.SOUTH KOREA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 67.SOUTH KOREA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 68.SOUTH KOREA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 69.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 70.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 71.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 72.LAMEA DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY, 2018–2026 ($MILLION)
- TABLE 73.LAMEA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 74.LAMEA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 75.LAMEA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 76.BRAZIL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 77.BRAZIL DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 78.BRAZIL DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 79.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 80.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 81.SAUDI ARABIA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 82.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 83.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 84.SOUTH AFRICA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 85.REST OF LAMEA DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2026 ($MILLION)
- TABLE 86.REST OF LAMEA DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2026 ($MILLION)
- TABLE 87.REST OF LAMEA DIGITAL PATHOLOGY MARKET REVENUE, BY END USER, 2018–2026 ($MILLION)
- TABLE 88.3DHISTECH: COMPANY SNAPSHOT
- TABLE 89.3DHISTECH: PRODUCT PORTFOLIO
- TABLE 90.DANAHER: COMPANY SNAPSHOT
- TABLE 91.DANAHER: OPERATING SEGMENTS
- TABLE 92.DANAHER: PRODUCT PORTFOLIO
- TABLE 93.GLENCOE SOFTWARE: COMPANY SNAPSHOT
- TABLE 94.GLENCOE SOFTWARE: PRODUCT PORTFOLIO
- TABLE 95.HAMAMATSU: COMPANY SNAPSHOT
- TABLE 96.HAMAMATSU: OPERATING SEGMENTS
- TABLE 97.HAMAMATSU: PRODUCT PORTFOLIO
- TABLE 98.INDICA LABS: COMPANY SNAPSHOT
- TABLE 99.INDICA LABS: PRODUCT PORTFOLIO
- TABLE 100.PHILIPS: COMPANY SNAPSHOT
- TABLE 101.PHILIPS: OPERATING SEGMENTS
- TABLE 102.PHILIPS: PRODUCT PORTFOLIO
- TABLE 103.NIKON: COMPANY SNAPSHOT
- TABLE 104.NIKON: OPERATING SEGMENTS
- TABLE 105.NIKON: PRODUCT PORTFOLIO
- TABLE 106.PERKINELMER: COMPANY SNAPSHOT
- TABLE 107.PERKINELMER: OPERATING SEGMENTS
- TABLE 108.PERKINELMER: PRODUCT PORTFOLIO
- TABLE 109.ROCHE: COMPANY SNAPSHOT
- TABLE 110.ROCHE: OPERATING SEGMENTS
- TABLE 111.ROCHE: PRODUCT PORTFOLIO
- TABLE 112.VISIOPHARM: COMPANY SNAPSHOT
- TABLE 113.VISIOPHARM: PRODUCT PORTFOLIO
- List of Figures
- FIGURE 01.GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION
- FIGURE 02.TOP INVESTMENT POCKETS, 2018
- FIGURE 03.HIGH BARGAINING POWER OF SUPPLIERS
- FIGURE 04.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 05.HIGH THREAT OF SUBSTITUTES
- FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
- FIGURE 07.MODERATE COMPETITIVE RIVALRY
- FIGURE 08.IMPACT ANALYSES
- FIGURE 09.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR SCANNER, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 10.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 11.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR STORAGE AND COMMUNICATION SYSTEMS, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR EDUCATIONAL SECTOR, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR CLINICAL SECTOR, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIGITAL PATHOLOGY MARKET FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2018 & 2026 (%)
- FIGURE 19.U.S. DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 20.CANADA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 21.MEXICO DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 22.GERMANY DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 23.FRANCE DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 24.UK DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 25.ITALY DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 26.SPAIN DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 27.REST OF EUROPE DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 28.JAPAN DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 29.CHINA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 30.AUSTRALIA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 31.INDIA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 32.SOUTH KOREA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 33.REST OF ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 34.BRAZIL DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 35.SAUDI ARABIA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 36.SOUTH AFRICA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 37.REST OF LAMEA DIGITAL PATHOLOGY MARKET, 2018–2026 ($MILLION)
- FIGURE 38.TOP PLAYER POSITIONING, 2018
- FIGURE 39.COMPETITIVE DASHBOARD
- FIGURE 40.COMPETITIVE HEATMAP OF KEY PLAYERS
- FIGURE 41.DANAHER: NET SALES, 2018–2020 ($MILLION)
- FIGURE 42.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 43.DANAHER: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 44.HAMAMATSU: NET SALES, 2018–2020 ($MILLION)
- FIGURE 45.PHILIPS: NET SALES, 2018–2020 ($MILLION)
- FIGURE 46.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 47.PHILIPS: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 48.NIKON: NET SALES, 2018–2020 ($MILLION)
- FIGURE 49.NIKON: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 50.NIKON: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 51.PERKINELMER: NET SALES, 2018–2020 ($MILLION)
- FIGURE 52.PERKINELMER: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 53.PERKINELMER: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 54.ROCHE: NET SALES, 2018–2020 ($MILLION)
- FIGURE 55.ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 56.ROCHE: REVENUE SHARE BY REGION, 2020 (%)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook